Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Oncternal Therapeutics Inc. buy HC Wainwright

Start price
€0.32
29.01.24 / 50%
Target price
€27.72
29.01.25
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 29.01.25. The prediction end date can be changed by HC_Wainwright at any time.
Performance without dividends (%)
Name 1w 1m
Oncternal Therapeutics Inc. - -
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by HC_Wainwright for this prediction

In the thread Oncternal Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 27.720
Change
Ends at 29.01.25

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target raised by analysts at HC Wainwright to $30.00. They now have a "buy" rating on the stock.
Ratings data for ONCT provided by MarketBeat

Stopped prediction by HC_Wainwright for Oncternal Therapeutics Inc.

buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.32
15.04.24
€26.28
15.04.25
-
05.01.24

buy
Oncternal Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
27.12.23
€1.81
27.12.24
-41.48%
05.01.24